Sign In
Buy GKOS
$113.64
+2.86 (+2.58%)
At Close: Jun 03, 2026
Glaukos Corp (NYSE:GKOS) Shares Acquired by Royce & Associates LP
05:46pm, Friday, 21'st Feb 2020
Royce & Associates LP grew its stake in Glaukos Corp (NYSE:GKOS) by 57.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The instit
Analysts Estimate Glaukos (GKOS) to Report a Decline in Earnings: What to Look Out for
05:31pm, Thursday, 20'th Feb 2020
Glaukos (GKOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Glaukos (GKOS) to Report a Decline in Earnings: What to Look Out for
05:31pm, Thursday, 20'th Feb 2020
Glaukos (GKOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Glaukos Corp (NYSE:GKOS) Stock Position Decreased by State Board of Administration of Florida Retirement System
03:48pm, Thursday, 20'th Feb 2020
State Board of Administration of Florida Retirement System trimmed its stake in Glaukos Corp (NYSE:GKOS) by 4.7% during the fourth quarter, according to its most recent filing with the Securities & Ex
What's in the Offing for LabCorp's (LH) Earnings in Q4?
03:52pm, Friday, 07'th Feb 2020
With near-term visibility seeming bleak at the moment, we anticipate PAMA to once again dent LabCorp's (LH) fourth-quarter top line.
What's in the Offing for LabCorp's (LH) Earnings in Q4?
03:52pm, Friday, 07'th Feb 2020
With near-term visibility seeming bleak at the moment, we anticipate PAMA to once again dent LabCorp's (LH) fourth-quarter top line.
What's in the Cards for DaVita (DVA) This Earnings Season?
12:42pm, Friday, 07'th Feb 2020
DaVita (DVA) expects to have gained from calcimimetics in the fourth quarter.
What's in the Cards for DaVita (DVA) This Earnings Season?
12:42pm, Friday, 07'th Feb 2020
DaVita (DVA) expects to have gained from calcimimetics in the fourth quarter.
Glaukos Corporation to Release Fourth Quarter and Full Year 2019 Financial Results after Market Close on February 27
09:15pm, Thursday, 06'th Feb 2020
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to
PROCEPT BioRobotics Appoints Reza Zadno, PhD, as New President and CEO
12:00pm, Thursday, 06'th Feb 2020
Surgical robotics company PROCEPT BioRobotics appoints medical device industry veteran Reza Zadno, PhD, as new president and CEO.
Nuvaira Announces Chief Financial Officer and Pivotal Study Milestone
02:55pm, Tuesday, 04'th Feb 2020
Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, has announced that Tom Griffin has joined Nuvaira as Chief Financial Officer.
BD Life Sciences to Aid Becton, Dickinson (BDX) Q1 Earnings
12:57pm, Tuesday, 04'th Feb 2020
BD's (BDX) core Life Sciences arm is expected to have driven first-quarter performance.
BD Life Sciences to Aid Becton, Dickinson (BDX) Q1 Earnings
12:57pm, Tuesday, 04'th Feb 2020
BD's (BDX) core Life Sciences arm is expected to have driven first-quarter performance.
Glaukos (NYSE:GKOS) Shareholders Have Enjoyed A 29% Share Price Gain
01:40pm, Saturday, 01'st Feb 2020
Glaukos Corporation (NYSE:GKOS) shareholders might be concerned after seeing the share price drop 14% in the last...
Comparing Glaukos (NYSE:GKOS) and SANUWAVE Health (NYSE:SNWV)
08:36am, Thursday, 30'th Jan 2020
Glaukos (NYSE:GKOS) and SANUWAVE Health (OTCMKTS:SNWV) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability,
